A Randomized, 26-week, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Dementia Secondary to Cerebrovascular Disease

Project: Research

StatusFinished
Effective start/end date1/01/0231/12/02